{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:24:09Z","timestamp":1790630649644,"version":"4.1.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009699","name":"Fondazione Generali","doi-asserted-by":"publisher","award":["GENERALBA_2017"],"award-info":[{"award-number":["GENERALBA_2017"]}],"id":[{"id":"10.13039\/501100009699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004229","name":"Fondazione Pierfranco e Luisa Mariani","doi-asserted-by":"publisher","award":["R-18-106"],"award-info":[{"award-number":["R-18-106"]}],"id":[{"id":"10.13039\/501100004229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001673","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","award":["#1681 session 2017B"],"award-info":[{"award-number":["#1681 session 2017B"]}],"id":[{"id":"10.13039\/501100001673","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neurogenesis impairment is a key determinant of intellectual disability in Down syndrome (DS), a genetic pathology due to triplication of chromosome 21. Since neurogenesis ceases after birth, apart in the hippocampus and olfactory bulb, the only means to tackle the problem of neurogenesis impairment in DS at its root is to intervene during gestation. A few studies in DS mouse models show that this is possible, although the drugs used may raise caveats in terms of safety. We previously found that neonatal treatment with 7,8-dihydroxyflavone (7,8-DHF), a flavonoid present in plants, restores hippocampal neurogenesis in the Ts65Dn model of DS. The goal of the current study was to establish whether prenatal treatment with 7,8-DHF improves\/restores overall brain proliferation potency. Pregnant Ts65Dn females received 7,8-DHF from embryonic day 10 until delivery. On postnatal day 2 (P2) the pups were injected with BrdU and were killed after either 2\u00a0h or 52\u201360\u00a0days (P52\u201360). Evaluation of the number of proliferating (BrdU+) cells in various forebrain neurogenic niches of P2 mice showed that in treated Ts65Dn mice proliferation potency was improved or even restored in most of the examined regions, including the hippocampus. Quantification of the surviving BrdU+\u2009cells in the dentate gyrus of P52\u201360 mice showed no difference between treated and untreated Ts65Dn mice. At P52\u201360, however, treated Ts65Dn mice exhibited a larger number of granule cells in comparison with their untreated counterparts, although their number did not reach that of euploid mice. Results show that 7,8-DHF has a widespread impact on prenatal proliferation potency in Ts65Dn mice and exerts mild long-term effects. It remains to be established whether treatment extending into the neonatal period can lead to an improvement in brain development that is retained in adulthood.<\/jats:p>","DOI":"10.1038\/s41598-021-85284-5","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T16:47:41Z","timestamp":1616086061000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome"],"prefix":"10.1038","volume":"11","author":[{"given":"Fiorenza","family":"Stagni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Uguagliati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Emili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giacomini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Bartesaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Guidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"key":"85284_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/hipo.20308","volume":"17","author":"A Contestabile","year":"2007","unstructured":"Contestabile, A. et al. Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice. Hippocampus 17, 665\u2013678. https:\/\/doi.org\/10.1002\/hipo.20308 (2007).","journal-title":"Hippocampus"},{"key":"85284_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1750-3639.2007.00113.x","volume":"18","author":"S Guidi","year":"2008","unstructured":"Guidi, S. et al. Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome. Brain Pathol. 18, 180\u2013197. https:\/\/doi.org\/10.1111\/j.1750-3639.2007.00113.x (2008).","journal-title":"Brain Pathol."},{"key":"85284_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1750-3639.2010.00459.x","volume":"21","author":"S Guidi","year":"2011","unstructured":"Guidi, S., Ciani, E., Bonasoni, P., Santini, D. & Bartesaghi, R. Widespread proliferation impairment and hypocellularity in the cerebellum of fetuses with Down syndrome. Brain Pathol. 21, 361\u2013373. https:\/\/doi.org\/10.1111\/j.1750-3639.2010.00459.x (2011).","journal-title":"Brain Pathol."},{"key":"85284_CR4","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1093\/hmg\/dds052","volume":"21","author":"J Lu","year":"2012","unstructured":"Lu, J. et al. OLIG2 over-expression impairs proliferation of human Down syndrome neural progenitors. Hum. Mol. Genet. 21, 2330\u20132340 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"85284_CR5","doi-asserted-by":"publisher","first-page":"11483","DOI":"10.1523\/JNEUROSCI.3406-07.2007","volume":"27","author":"L Chakrabarti","year":"2007","unstructured":"Chakrabarti, L., Galdzicki, Z. & Haydar, T. F. Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome. J. Neurosci. 27, 11483\u201311495 (2007).","journal-title":"J. Neurosci."},{"key":"85284_CR6","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1093\/cercor\/bhp176","volume":"20","author":"K Ishihara","year":"2010","unstructured":"Ishihara, K. et al. Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome. Cereb. Cortex 20, 1131\u20131143 (2010).","journal-title":"Cereb. Cortex"},{"key":"85284_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11065-010-9148-4","volume":"20","author":"J Stiles","year":"2010","unstructured":"Stiles, J. & Jernigan, T. L. The basics of brain development. Neuropsychol. Rev. 20, 327\u2013348 (2010).","journal-title":"Neuropsychol. Rev."},{"key":"85284_CR8","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S0306-4522(01)00156-7","volume":"105","author":"L Seress","year":"2001","unstructured":"Seress, L., Abraham, H., Tornoczky, T. & Kosztolanyi, G. Cell formation in the human hippocampal formation from mid-gestation to the late postnatal period. Neuroscience 105, 831\u2013843 (2001).","journal-title":"Neuroscience"},{"issue":"Suppl 3","key":"85284_CR9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1289\/ehp.00108s3511","volume":"108","author":"D Rice","year":"2010","unstructured":"Rice, D. & Barone, S. Critical periods of vulnerabiliy for the developing nervpus system: evidence from humans and animal models. Environ. Health Perspect. 108(Suppl 3), 511\u2013533 (2010).","journal-title":"Environ. Health Perspect."},{"key":"85284_CR10","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/3305","volume":"4","author":"PS Eriksson","year":"1998","unstructured":"Eriksson, P. S. et al. Neurogenesis in the adult human hippocampus. Nat. Med. 4, 1313\u20131317 (1998).","journal-title":"Nat. Med."},{"key":"85284_CR11","doi-asserted-by":"publisher","first-page":"8769","DOI":"10.1523\/JNEUROSCI.0534-10.2010","volume":"30","author":"P Bianchi","year":"2010","unstructured":"Bianchi, P. et al. Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome. J. Neurosci. 30, 8769\u20138779 (2010).","journal-title":"J. Neurosci."},{"key":"85284_CR12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.nbd.2014.12.005","volume":"74C","author":"F Stagni","year":"2015","unstructured":"Stagni, F. et al. Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice. Neurobiol. Dis. 74C, 204\u2013218. https:\/\/doi.org\/10.1016\/j.nbd.2014.12.005 (2015).","journal-title":"Neurobiol. Dis."},{"key":"85284_CR13","first-page":"120","volume":"16","author":"F Stagni","year":"2014","unstructured":"Stagni, F. et al. Treatment with Epigallocatechin Gallate rescues neurogenesis and neuron maturation in the Ts65Dn mouse model of Down syndrome. XXII National Congress of the Italian Society of Psychophysiology. 27th-29th November 2014. Neuopsychol. Trends 16, 120 (2014).","journal-title":"Neuopsychol. Trends"},{"key":"85284_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.expneurol.2017.08.018","volume":"298","author":"F Stagni","year":"2017","unstructured":"Stagni, F. et al. A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS. Exp. Neurol. 298, 79\u201396. https:\/\/doi.org\/10.1016\/j.expneurol.2017.08.018 (2017).","journal-title":"Exp. Neurol."},{"key":"85284_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.nbd.2019.05.005","volume":"129","author":"F Stagni","year":"2019","unstructured":"Stagni, F. et al. Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome. Neurobiol. Dis. 129, 44\u201355. https:\/\/doi.org\/10.1016\/j.nbd.2019.05.005 (2019).","journal-title":"Neurobiol. Dis."},{"key":"85284_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.nbd.2015.08.001","volume":"82","author":"A Giacomini","year":"2015","unstructured":"Giacomini, A. et al. Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome. Neurobiol. Dis. 82, 385\u2013396. https:\/\/doi.org\/10.1016\/j.nbd.2015.08.001 (2015).","journal-title":"Neurobiol. Dis."},{"key":"85284_CR17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.expneurol.2006.02.005","volume":"200","author":"S Clark","year":"2006","unstructured":"Clark, S., Schwalbe, J., Stasko, M. R., Yarowsky, P. J. & Costa, A. C. Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome. Exp. Neurol. 200, 256\u2013261 (2006).","journal-title":"Exp. Neurol."},{"key":"85284_CR18","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/NEN.0b013e318236e9ad","volume":"70","author":"J Blanchard","year":"2011","unstructured":"Blanchard, J. et al. Rescue of synaptic failure and alleviation of learning and memory impairments in a trisomic mouse model of down syndrome. J. Neuropathol. Exp. Neurol. 70, 1070\u20131079 (2011).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"85284_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/jpi.12097","volume":"56","author":"A Corrales","year":"2014","unstructured":"Corrales, A. et al. Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome. J. Pineal Res. 56, 51\u201361 (2014).","journal-title":"J. Pineal Res."},{"key":"85284_CR20","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1172\/JCI64650","volume":"123","author":"A Contestabile","year":"2013","unstructured":"Contestabile, A. et al. Lithium rescues synaptic plasticity and memory in Down syndrome mice. J. Clin. Investig. 123, 348\u2013361 (2013).","journal-title":"J. Clin. Investig."},{"key":"85284_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neulet.2015.02.008","volume":"591","author":"SE Latchney","year":"2015","unstructured":"Latchney, S. E., Jaramillo, T. C., Rivera, P. D., Eisch, A. J. & Powell, C. M. Chronic P7C3 treatment restores hippocampal neurogenesis. Neurosci. Lett. 591, 86\u201392 (2015).","journal-title":"Neurosci. Lett."},{"key":"85284_CR22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/brain\/awt340","volume":"137","author":"S Guidi","year":"2014","unstructured":"Guidi, S. et al. Prenatal pharmacotherapy rescues brain development in a Down\u2019s syndrome mouse model. Brain 137, 380\u2013401. https:\/\/doi.org\/10.1093\/brain\/awt340 (2014).","journal-title":"Brain"},{"key":"85284_CR23","doi-asserted-by":"publisher","first-page":"9871","DOI":"10.1096\/fj.201802669RR","volume":"33","author":"MJ Alldred","year":"2019","unstructured":"Alldred, M. J. et al. Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer\u2019s disease. FASEB J. 33, 9871\u20139884. https:\/\/doi.org\/10.1096\/fj.201802669RR (2019).","journal-title":"FASEB J."},{"key":"85284_CR24","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.neuroscience.2016.11.001","volume":"340","author":"BE Powers","year":"2017","unstructured":"Powers, B. E. et al. Maternal choline supplementation in a mouse model of Down syndrome: effects on attention and nucleus basalis\/substantia innominata neuron morphology in adult offspring. Neuroscience 340, 501\u2013514. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.11.001 (2017).","journal-title":"Neuroscience"},{"key":"85284_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.nbd.2013.04.016","volume":"58","author":"R Velazquez","year":"2013","unstructured":"Velazquez, R. et al. Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome. Neurobiol. Dis. 58, 92\u2013101 (2013).","journal-title":"Neurobiol. Dis."},{"key":"85284_CR26","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1096\/fj.201700692RR","volume":"32","author":"MA Caudill","year":"2018","unstructured":"Caudill, M. A., Strupp, B. J., Muscalu, L., Nevins, J. E. H. & Canfield, R. L. Maternal choline supplementation during the third trimester of pregnancy improves infant information processing speed: a randomized, double-blind, controlled feeding study. FASEB J. 32, 2172\u20132180. https:\/\/doi.org\/10.1096\/fj.201700692RR (2018).","journal-title":"FASEB J."},{"key":"85284_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fnbeh.2015.00265","volume":"9","author":"F Stagni","year":"2015","unstructured":"Stagni, F., Giacomini, A., Guidi, S., Ciani, E. & Bartesaghi, R. Timing of therapies for Down syndrome: the sooner, the better. Front. Behav. Neurosci. 9, 265 (2015).","journal-title":"Front. Behav. Neurosci."},{"key":"85284_CR28","doi-asserted-by":"publisher","first-page":"10268","DOI":"10.1073\/pnas.1704143114","volume":"114","author":"A Nakano-Kobayashi","year":"2017","unstructured":"Nakano-Kobayashi, A. et al. Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice. Proc. Natl. Acad. Sci. USA 114, 10268\u201310273. https:\/\/doi.org\/10.1073\/pnas.1704143114 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"85284_CR29","doi-asserted-by":"publisher","first-page":"h3190","DOI":"10.1136\/bmj.h3190","volume":"350","author":"J Reefhuis","year":"2015","unstructured":"Reefhuis, J., Devine, O., Friedman, J. M., Louik, K. & Honein, M. Specific SSRIs and birth defects: bayesian analysis to interpret new data in the context of previous reports. BMJ 350, h3190 (2015).","journal-title":"BMJ"},{"key":"85284_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/DDDT.S96936","volume":"10","author":"F Moosavi","year":"2016","unstructured":"Moosavi, F., Hosseini, R., Saso, L. & Firuzi, O. Modulation of neurotrophic signaling pathways by polyphenols. Drug Des. Devel. Ther. 10, 23\u201342. https:\/\/doi.org\/10.2147\/DDDT.S96936 (2016).","journal-title":"Drug Des. Devel. Ther."},{"key":"85284_CR31","doi-asserted-by":"publisher","first-page":"8274","DOI":"10.1021\/jm101206p","volume":"53","author":"X Liu","year":"2010","unstructured":"Liu, X. et al. A synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect. J. Med. Chem. 53, 8274\u20138286 (2010).","journal-title":"J. Med. Chem."},{"key":"85284_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000346920","volume":"91","author":"X Liu","year":"2013","unstructured":"Liu, X. et al. O-methylated metabolite of 7,8-dihydroxyflavone activates TrkB receptor and displays antidepressant activity. Pharmacology 91, 185\u2013200 (2013).","journal-title":"Pharmacology"},{"key":"85284_CR33","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3233\/JAD-2012-120886","volume":"31","author":"Y Zeng","year":"2012","unstructured":"Zeng, Y., Liu, Y., Wu, M., Liu, J. & Hu, Q. Activation of TrkB by 7,8-dihydroxyflavone prevents fear memory defects and facilitates amygdalar synaptic plasticity in aging. J. Alzheimers Dis. 31, 765\u2013778. https:\/\/doi.org\/10.3233\/JAD-2012-120886 (2012).","journal-title":"J. Alzheimers Dis."},{"key":"85284_CR34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.neuint.2015.07.021","volume":"89","author":"X Du","year":"2015","unstructured":"Du, X. & Hill, R. A. 7,8-Dihydroxyflavone as a pro-neurotrophic treatment for neurodevelopmental disorders. Neurochem. Int. 89, 170\u2013180 (2015).","journal-title":"Neurochem. Int."},{"key":"85284_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0301-0082(03)00002-9","volume":"69","author":"CY Brazel","year":"2003","unstructured":"Brazel, C. Y., Romanko, M. J., Rothstein, R. P. & Levison, S. W. Roles of the mammalian subventricular zone in brain development. Prog. Neurobiol. 69, 49\u201369 (2003).","journal-title":"Prog. Neurobiol."},{"key":"85284_CR36","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1523\/JNEUROSCI.16-19-06183.1996","volume":"16","author":"T Takahashi","year":"1996","unstructured":"Takahashi, T., Nowakowski, R. S. & Caviness, V. S. Jr. The leaving or Q fraction of the murine cerebral proliferative epithelium: a general model of neocortical neuronogenesis. J. Neurosci. 16, 6183\u20136196 (1996).","journal-title":"J. Neurosci."},{"key":"85284_CR37","first-page":"1","volume":"2","author":"JB Angevine Jr","year":"1965","unstructured":"Angevine, J. B. Jr. Time of neuron origin in the hippocampal region. An autoradiographic study in the mouse. Exp. Neurol. 2, 1\u201370 (1965).","journal-title":"Exp. Neurol."},{"key":"85284_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-1-4684-2976-3_4","volume-title":"The Hippocampus","author":"JBJ Angevine","year":"1975","unstructured":"Angevine, J. B. J. Development of the hippocampal region. In The Hippocampus Vol. 1 (eds Isaacson, R. L. & Pribram, K. H.) 61\u201391 (Plenum Press, New York, 1975)."},{"key":"85284_CR39","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/BF00315705","volume":"163","author":"JC Fentress","year":"1981","unstructured":"Fentress, J. C., Stanfield, B. B. & Cowan, W. M. Observation on the development of the striatum in mice and rats. Anat. Embryol. (Berl) 163, 275\u2013298 (1981).","journal-title":"Anat. Embryol. (Berl)"},{"key":"85284_CR40","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/cne.22531","volume":"519","author":"A Suzuki-Hirano","year":"2011","unstructured":"Suzuki-Hirano, A. et al. Dynamic spatiotemporal gene expression in embryonic mouse thalamus. J. Comp. Neurol. 519, 528\u2013543 (2011).","journal-title":"J. Comp. Neurol."},{"key":"85284_CR41","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1210\/en.2012-1328","volume":"153","author":"Y Ishii","year":"2012","unstructured":"Ishii, Y. & Bouret, S. G. Embryonic birthdate of hypothalamic leptin-activated neurons in mice. Endocrinology 153, 3657\u20133667 (2012).","journal-title":"Endocrinology"},{"key":"85284_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-1-4684-2976-3_5","volume-title":"The Hippocampus","author":"J Altman","year":"1975","unstructured":"Altman, J. & Bayer, S. Postnatal development of the hippocampal dentate gyrus under normal and experimental conditions. In The Hippocampus Vol. 1 (eds Isaacson, R. L. & Pribram, K. H.) 95\u2013122 (Plenum Press, New York, 1975)."},{"key":"85284_CR43","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0959-4388(02)00322-7","volume":"12","author":"CM Sauvageot","year":"2002","unstructured":"Sauvageot, C. M. & Stiles, C. D. Molecular mechanisms controlling cortical gliogenesis. Curr. Opin. Neurobiol. 12, 244\u2013249 (2002).","journal-title":"Curr. Opin. Neurobiol."},{"key":"85284_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neulet.2016.10.035","volume":"635","author":"MW Zhang","year":"2016","unstructured":"Zhang, M. W., Zhang, S. F., Li, Z. H. & Han, F. 7,8-Dihydroxyflavone reverses the depressive symptoms in mouse chronic mild stress. Neurosci. Lett. 635, 33\u201338. https:\/\/doi.org\/10.1016\/j.neulet.2016.10.035 (2016).","journal-title":"Neurosci. Lett."},{"key":"85284_CR45","doi-asserted-by":"publisher","first-page":"36087","DOI":"10.1038\/srep36087","volume":"6","author":"M Han","year":"2016","unstructured":"Han, M. et al. Intake of 7,8-dihydroxyflavone during juvenile and adolescent stages prevents onset of psychosis in adult offspring after maternal immune activation. Sci. Rep. 6, 36087. https:\/\/doi.org\/10.1038\/srep36087 (2016).","journal-title":"Sci. Rep."},{"key":"85284_CR46","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00406-017-0802-1","volume":"267","author":"M Han","year":"2017","unstructured":"Han, M., Zhang, J. C., Huang, X. F. & Hashimoto, K. Intake of 7,8-dihydroxyflavone from pregnancy to weaning prevents cognitive deficits in adult offspring after maternal immune activation. Eur. Arch. Psychiatry Clin. Neurosci. 267, 479\u2013483. https:\/\/doi.org\/10.1007\/s00406-017-0802-1 (2017).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"85284_CR47","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.1523\/JNEUROSCI.15-08-05765.1995","volume":"15","author":"S Ahmed","year":"1995","unstructured":"Ahmed, S., Reynolds, B. A. & Weiss, S. BDNF enhances the differentiation but not the survival of CNS stem cell-derived neuronal precursors. J. Neurosci. 15, 5765\u20135778 (1995).","journal-title":"J. Neurosci."},{"key":"85284_CR48","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1111\/j.1460-9568.2007.05818.x","volume":"26","author":"S Chiaramello","year":"2007","unstructured":"Chiaramello, S. et al. BDNF\/ TrkB interaction regulates migration of SVZ precursor cells via PI3-K and MAP-K signalling pathways. Eur. J. Neurosci. 26, 1780\u20131790. https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05818.x (2007).","journal-title":"Eur. J. Neurosci."},{"key":"85284_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2174\/156720209787466028","volume":"6","author":"O Islam","year":"2009","unstructured":"Islam, O., Loo, T. X. & Heese, K. Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT, and STAT-3 signaling pathways. Curr. Neurovasc. Res. 6, 42\u201353. https:\/\/doi.org\/10.2174\/156720209787466028 (2009).","journal-title":"Curr. Neurovasc. Res."},{"key":"85284_CR50","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1534\/genetics.105.050898","volume":"172","author":"RJ Roper","year":"2006","unstructured":"Roper, R. J., St John, H. K., Philip, J., Lawler, A. & Reeves, R. H. Perinatal loss of Ts65Dn Down syndrome mice. Genetics 172, 437\u2013443 (2006).","journal-title":"Genetics"},{"key":"85284_CR51","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/cne.20337","volume":"480","author":"PV Belichenko","year":"2004","unstructured":"Belichenko, P. V. et al. Synaptic structural abnormalities in the Ts65Dn mouse model of Down syndrome. J. Comp. Neurol. 480, 281\u2013298. https:\/\/doi.org\/10.1002\/cne.20337 (2004).","journal-title":"J. Comp. Neurol."},{"key":"85284_CR52","doi-asserted-by":"publisher","first-page":"13333","DOI":"10.1073\/pnas.93.23.13333","volume":"93","author":"DM Holtzman","year":"1996","unstructured":"Holtzman, D. M. et al. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc. Natl. Acad. Sci. USA 93, 13333\u201313338 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"85284_CR53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2017.07.026","volume":"114","author":"F Stagni","year":"2018","unstructured":"Stagni, F., Giacomini, A., Emili, M., Guidi, S. & Bartesaghi, R. Neurogenesis impairment: an early developmental defect in Down syndrome. Free Radic. Biol. Med. 114, 15\u201332 (2018).","journal-title":"Free Radic. Biol. Med."},{"key":"85284_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1749-8104-6-35","volume":"6","author":"L Wang","year":"2011","unstructured":"Wang, L., Bluske, K. K., Dickel, L. K. & Nakagawa, Y. Basal progenitor cells in the embryonic mouse thalamus\u2014their molecular characterization and the role of neurogenins and Pax6. Neural Dev. 6, 35 (2011).","journal-title":"Neural Dev."},{"key":"85284_CR55","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neurobiolaging.2018.11.009","volume":"75","author":"JC Perry","year":"2018","unstructured":"Perry, J. C., Pakkenberg, B. & Vann, S. D. Striking reduction in neurons and glial cells in anterior thalamic nuclei of older patients with Down syndrome. Neurobiol. Aging 75, 54\u201361. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.11.009 (2018).","journal-title":"Neurobiol. Aging"},{"key":"85284_CR56","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.neuroscience.2014.08.046","volume":"279","author":"AS Karlsen","year":"2014","unstructured":"Karlsen, A. S., Korbo, S., Uylings, H. B. & Pakkenberg, B. A stereological study of the mediodorsal thalamic nucleus in Down syndrome. Neuroscience 279, 253\u2013259. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.08.046 (2014).","journal-title":"Neuroscience"},{"key":"85284_CR57","doi-asserted-by":"publisher","first-page":"45561","DOI":"10.1038\/srep45561","volume":"7","author":"SF Kazim","year":"2017","unstructured":"Kazim, S. F., Blanchard, J., Bianchi, R. & Iqbal, K. Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer\u2019s-like memory deficits in the Ts65Dn mouse model of Down syndrome. Sci. Rep. 7, 45561. https:\/\/doi.org\/10.1038\/srep45561 (2017).","journal-title":"Sci. Rep."},{"key":"85284_CR58","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-3-7091-6721-2_14","volume":"67","author":"U Unterberger","year":"2003","unstructured":"Unterberger, U. et al. The cerebral cortex in fetal Down syndrome. J. Neural Transm. Suppl. 67, 159\u2013163 (2003).","journal-title":"J. Neural Transm. Suppl."},{"key":"85284_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(81)90314-0","volume":"225","author":"S Takashima","year":"1981","unstructured":"Takashima, S., Becker, L. E., Armstrong, D. L. & Chan, F. Abnormal neuronal development in the visual cortex of the human fetus and infant with down\u2019s syndrome. A quantitative and qualitative Golgi study. Brain Res. 225, 1\u201321. https:\/\/doi.org\/10.1016\/0006-8993(81)90314-0 (1981).","journal-title":"Brain Res."},{"key":"85284_CR60","first-page":"274","volume":"7","author":"KE Wisniewski","year":"1990","unstructured":"Wisniewski, K. E. Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis. Am. J. Med. Genet. Suppl. 7, 274\u2013281 (1990).","journal-title":"Am. J. Med. Genet. Suppl."},{"key":"85284_CR61","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1212\/WNL.34.7.909","volume":"34","author":"MH Ross","year":"1984","unstructured":"Ross, M. H., Galaburda, A. M. & Kemper, T. L. Down\u2019s syndrome: is there a decreased population of neurons?. Neurology 34, 909\u2013916 (1984).","journal-title":"Neurology"},{"key":"85284_CR62","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1001\/archneurpsyc.1928.02210180080004","volume":"20","author":"LM Davidoff","year":"1928","unstructured":"Davidoff, L. M. The brain in mongolian idiocy: a report of ten cases. Arch. Neurol. Psychiatry 20, 1229\u20131257. https:\/\/doi.org\/10.1001\/archneurpsyc.1928.02210180080004 (1928).","journal-title":"Arch. Neurol. Psychiatry"},{"key":"85284_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/antiox8060163","author":"A Giacomini","year":"2019","unstructured":"Giacomini, A. et al. Timing of treatment with the flavonoid 7,8-DHF critically impacts on its effects on learning and memory in the Ts65Dn mouse. Antioxidants (Basel) https:\/\/doi.org\/10.3390\/antiox8060163 (2019).","journal-title":"Antioxidants (Basel)"},{"key":"85284_CR64","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00335-011-9357-z","volume":"22","author":"LG Reinholdt","year":"2011","unstructured":"Reinholdt, L. G. et al. Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn. Mamm. Genome 22, 685\u2013691. https:\/\/doi.org\/10.1007\/s00335-011-9357-z (2011).","journal-title":"Mamm. Genome"},{"key":"85284_CR65","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.neuroscience.2016.07.031","volume":"333","author":"F Stagni","year":"2016","unstructured":"Stagni, F. et al. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome. Neuroscience 333, 277\u2013301. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.07.031 (2016).","journal-title":"Neuroscience"},{"key":"85284_CR66","first-page":"356","volume-title":"Atlas of the Developing Mouse Brain","author":"G Paxinos","year":"2007","unstructured":"Paxinos, G., Halliday, G., Watson, C., Koutcherov, Y. & Wang, H. Atlas of the Developing Mouse Brain 356 (Elsevier, Academic Press, 2007)."},{"key":"85284_CR67","doi-asserted-by":"publisher","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","volume":"20","author":"JE Malberg","year":"2000","unstructured":"Malberg, J. E., Eisch, A. J., Nestler, E. J. & Duman, R. S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20, 9104\u20139110 (2000).","journal-title":"J. Neurosci."},{"key":"85284_CR68","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.neuron.2005.08.023","volume":"47","author":"Y Tozuka","year":"2005","unstructured":"Tozuka, Y., Fukuda, S., Namba, T., Seki, T. & Hisatsune, T. GABAergic excitation promotes neuronal differentiation in adult hippocampal progenitor cells. Neuron 47, 803\u2013815 (2005).","journal-title":"Neuron"},{"key":"85284_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-3806(01)00224-3","volume":"134","author":"G Kempermann","year":"2002","unstructured":"Kempermann, G. & Gage, F. H. Genetic influence on phenotypic differentiation in adult hippocampal neurogenesis. Brain Res. Dev. Brain Res. 134, 1\u201312 (2002).","journal-title":"Brain Res. Dev. Brain Res."},{"key":"85284_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cne.902960102","volume":"296","author":"MJ West","year":"1990","unstructured":"West, M. J. & Gundersen, H. J. Unbiased stereological estimation of the number of neurons in the human hippocampus. J. Comp. Neurol. 296, 1\u201322 (1990).","journal-title":"J. Comp. Neurol."},{"key":"85284_CR71","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.neuroscience.2004.12.015","volume":"132","author":"S Severi","year":"2005","unstructured":"Severi, S., Guidi, S., Ciani, E. & Bartesaghi, R. Sex differences in the stereological parameters of the hippocampal dentate gyrus of the guinea-pig before puberty. Neuroscience 132, 375\u2013387 (2005).","journal-title":"Neuroscience"},{"key":"85284_CR72","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","volume":"147","author":"H Gundersen","year":"1987","unstructured":"Gundersen, H. & Jensen, E. The efficiency of systematic sampling in stereology and its prediction. J. Microsc. 147, 229\u2013263 (1987).","journal-title":"J. Microsc."},{"key":"85284_CR73","unstructured":"Kuehne, C. C. Kuehne, C. C. The Advantages of Using Planned Comparisons over Post Hoc Tests [microform]\/Carolyn C. Kuehne (Distributed by ERIC Clearinghouse, 1993)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85284-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85284-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85284-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T05:29:50Z","timestamp":1670045390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85284-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["85284"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-85284-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"assertion":[{"value":"23 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6300"}}